1 not yet recruiting, 1 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Older Patients: new trials by email Literature Review of Older Patients trials Research Report on Older Patients
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT Venetoclax (VEN), Decitabine (DAC), Busulfan (Bu) - Older Patients, Myeloid Malignancies | Phase 2 / Phase 3 | Not yet recruiting | Nanfang Hospital, Southern Medical University | 160 | 2025-07-15 | 2025-07-04 |
| Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT venetoclax combining with fludarabine and melphalan - Hematologic Malignancy, Older Patients | Phase 2 | Unknown | First Affiliated Hospital of Zhejiang University | 50 | 2021-10-07 | 2021-10-27 |
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Neoplasms (1) · Neoplasms by Site (1)
fludarabine (2) · Busulfan (1) · Decitabine (1) · Influenza Vaccines (1) · Melphalan (1) · venetoclax (1)
First Affiliated Hospital of Zhejiang University (1) · Nanfang Hospital, Southern Medical University (1)
China (1)
Qifa Liu (1) · Yi Luo, M.D. (1)